The device was received for evaluation and passed testing that ensures functionality of the device and sensors.A review of the device history record confirmed the product was released meeting all quality criteria and manufacturing specifications.Factors outside the scope of nxstage therapy can impact the patient''s weight, these include but are not limited to the accuracy with which intake is recorded, the weighing techniques used, and the patient's comorbidities.Udi: (b)(4).
|
A report was received on 02 sep 2020 from the home therapy nurse (htn) of a (b)(6) male with a medical history of hypertension, chronic hypoxemic respiratory failure, obesity, type ii diabetes chronic anemia and end stage renal disease, who stated insufficient fluid was removed and the patient experienced shortness of breath during hemodialysis treatment on (b)(6) 2020.The patient was admitted to hospital for fluid overload on (b)(6) 2020.Additional information was received 14-15 sep 2020 from the htn who stated the patient had experienced shortness of breath and insufficient fluid removal for several days prior to the event.The patient was admitted 2 sep 2020 with acute on chronic hypoxemic respiratory failure, secondary to pulmonary edema and fluid overload and uncontrolled hypertension.The course of hospitalization included investigation of elevated troponin and procalcitonin, antibiotics for suspected pneumonia, adjustment of blood pressure medication, noninvasive bipap ventilation and dialysis to control volume status.They received instruction regarding home hemodialysis treatments and weight management.Symptoms resolved, the patient improved and was discharged on (b)(6) 2020 to continue home hemodialysis treatments utilizing the nxstage system.
|